Core Viewpoint - The Hong Kong stock market has become a central arena for global capital to invest in China's consumption upgrade, particularly in the beauty and health sectors, driven by strong internal growth dynamics in "self-care" consumption [1] Industry Overview - The Chinese cosmetics industry is experiencing a new phase of structural adjustment, maintaining its position as the second-largest market globally, with expectations of entering a quality improvement stage over the next five years [2] - Chinese beauty brands are no longer content with being alternatives to foreign brands but are now competing on equal footing [2] Company Performance - Natural堂 has shown steady financial growth, with revenue increasing from 4.292 billion RMB in 2022 to 4.601 billion RMB in 2024, and recording 2.448 billion RMB in the first half of 2025 [2] - The company's gross profit rose from 2.852 billion RMB in 2022 to approximately 3.195 billion RMB in 2024, with gross margin increasing from 66.5% to 69.4% during the same period [3] - In the first half of 2025, net profit reached 191 million RMB, with a net profit margin of 7.8%, showing significant improvement compared to 2024 [3] Brand Strength and Market Position - Natural堂 is the second-largest domestic cosmetics brand in China by retail sales in 2024 and has consistently ranked among the top two brands for 12 consecutive years from 2013 to 2024 [4] - The company has launched a multi-brand strategy, covering various market segments from mass to mid-high end, with a total of 522 SKUs as of June 2025 [4] Sales Channels and Growth Strategy - The online sales channel's revenue share increased from 59.7% in 2022 to 68.8% in the first half of 2025, indicating a strong digital presence [4] - The company is enhancing its offline presence by opening flagship stores in major shopping centers, with the first store launched in Shenzhen in July 2025 [5] Research and Development - Natural堂 has invested 392.5 million RMB in R&D from 2022 to the first half of 2025, focusing on developing proprietary ingredients and technology [7] - The company has established a strong R&D team, with over 40% of its 154 professionals holding master's degrees or higher [8] - Natural堂 has developed proprietary ingredients like 喜默因, which has been incorporated into 86 product formulas, showcasing its innovation capabilities [9] Digital Transformation - The company has implemented a digital platform called "One Inventory System," enhancing operational efficiency and inventory management [10] - Natural堂's vertical production system, which includes three factories, ensures product quality and rapid market response [11] Conclusion - The Hong Kong stock market is witnessing a dual opportunity for valuation recovery and growth, with Natural堂 presenting a robust image of a financially sound, brand-strong, and R&D-leading Chinese beauty brand [12] - The company's transformation aligns with industry trends and market expectations, positioning it as a potential leader in the global beauty sector [12]

Core Insights - Shanghai Shangmei Cosmetics Co., Ltd. reported a revenue of 67.93 billion yuan for 2024, marking a significant year-on-year increase of 62.1% [1] - The net profit reached 803 million yuan, reflecting a substantial growth of 74% compared to the previous year [1] - The gross profit margin improved by 3.1 percentage points to 75.2% [1] Financial Performance - Sales expenses surged by 76.2% to 3.947 billion yuan, accounting for 58.1% of total revenue [4] - Research and development investment amounted to 180 million yuan, a year-on-year increase of 43%, but the proportion decreased from 3% to 2.6% [4] - Operating cash flow net amount was 5.47 billion yuan, showing a decline of 26.7% year-on-year [4] Brand Performance - The Han Shu brand generated revenue of 5.591 billion yuan, an impressive increase of 80.9%, contributing 82.3% to total revenue [4] - The Newpage brand achieved revenue of 376 million yuan, a remarkable rise of 146.3%, surpassing the One Leaf brand to become the second business pillar [4] - One Leaf brand revenue decreased by 35.7% to 229 million yuan, indicating a need for rejuvenation [4] New Initiatives - The company is preparing to launch a high-end anti-aging brand TAZUIP in collaboration with the mother and baby brand Anpanman [4] - In 2024, the company is also expanding into new fields such as medical beauty and equipment [4] - The self-developed ingredient "Cyclohexapeptide-9" used in the Hongman Waist series received three invention patents, with 76 new patent applications filed in 2024, including 36 inventions [4] Sales Channels - The company heavily relies on online sales channels, with online sales accounting for 90.5% of total sales [5] - Self-operated e-commerce sales grew by 82.6% to 5.312 billion yuan [5] - Offline distribution saw a year-on-year increase of 63.9%, while retail channels experienced a decline of 15.2% [5]